Epigenetic Modifications and Non-Coding RNA in Diabetes-Mellitus-Induced Coronary Artery Disease: Pathophysiological...

Area of Science:

• Endocrinology
• Cardiology
• Epigenetics

Background:

• Diabetes mellitus (DM) is a metabolic disorder causing chronic hyperglycemia.
• DM significantly increases the risk of cardiovascular disease (CVD), particularly coronary artery disease (CAD).
• Endothelial dysfunction due to hyperglycemia is a primary factor in diabetic vascular complications, but mechanisms require further elucidation.

Purpose of the Study:

• To review current knowledge on the pathophysiological links between DM and CAD.
• To focus on the role of epigenetic modifications in the pathogenesis of diabetic cardiovascular complications.
• To explore the potential of epigenetics in developing novel therapeutic strategies and biomarkers.

Main Methods:

• Literature review of current research on DM, CAD, and epigenetics.
• Analysis of the roles of DNA methylation, histone modifications, and noncoding RNAs.
• Examination of the implications for pharmacological treatments and diagnostic biomarkers.

Main Results:

• Epigenetic modifications, including DNA methylation, histone modifications, and noncoding RNAs, are implicated in the pathophysiology linking DM and CAD.
• Epigenetic targets are being explored for new pharmacological treatments ('epidrugs'), though challenges remain.
• Epigenetic biomarkers show promise for predicting and detecting diabetes complications.

Conclusions:

• Epigenetic mechanisms are crucial in understanding the interplay between DM and CAD.
• Further research into diabetes and CAD epigenetics is essential for identifying new therapeutic targets.
• Epigenetic insights can advance personalized medicine for managing diabetic cardiovascular disease, including predicting drug responses and minimizing adverse effects.